BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Gintemetostat readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Gintemetostat\, from ClinicalTrials.gov e
 stimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05651932-3127@assetmemo.bio
DTSTAMP:20261121T005646Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:Gintemetostat: Phase 1 readout est. (NCT05651932)
DESCRIPTION:Gintemetostat\, phase 1\, Multiple Myeloma.\nStudy: A Study of 
 an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myelo
 ma\nEstimated primary completion: 31 December 2027. This is a ClinicalTria
 ls.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pa
 ge: https://assetmemo.bio/drug/gintemetostat#upcoming-events\nRegistry rec
 ord: https://clinicaltrials.gov/study/NCT05651932
URL:https://assetmemo.bio/drug/gintemetostat#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
